All Categories
Business
Entertainment
Health
Finance
Other
Category
Medicine and Healthcare
Press Release
Feb 27, 2025
Jaguar Health Adopts Limited Duration Stockholder Rights Plan to Ensure Stockholders Can Realize Long-Term Value
Jaguar expects first results in Q2 2025 of proof-of-concept investigator-initiated trials of crofelemer for the rare diseases short bowel syndrome with intestinal failure and microvillus inclusion disease FDA meeting expected in Q2 2025 on the statistically significant results of the Phase 3 OnTarget trial of crofelemer in the prespecified subgroup of patients with breast cancer Jaguar has received an indication of interest to acquire the Company
Read More
Press Release
Feb 27, 2025
Bionic Bloom Announces Groundbreaking Non-ABA Therapy Framework: Empowerment-Based Integrated Treatment (EBiT)
A Revolutionary, Neurodivergent-Affirming Approach to Mental Health and Well-Being
Read More
Press Release
Feb 27, 2025
Interactive Strength Inc. (Nasdaq:TRNR) Quickly Receives Repeat Six-Figure CLMBR Order in Germany
Latest purchase confirms significant demand for CLMBR in Germany, quickly following on the initial order that was fulfilled in the Fall of 2024 Growing demand strengthens distributor relationship and validates TRNR's acquisition of German market leader Sportstech Germany is the largest fitness market after the United States
Read More
Press Release
Feb 26, 2025
Natural Dior LLC Issues Voluntary Nationwide Recall of Vitafer-L Gold Liquid Due to Presence of Undeclared Tadalafil
Read More
Press Release
Feb 26, 2025
ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results
Achieved Record Revenue for 2024 and Growth of 31%; Reduced 2024 Operational Cash Burn by 35%
Read More
Press Release
Feb 26, 2025
Merger with CLS Health Solves Challenges for Long-Established Houston Region Medical Practice
Case study shows Southeast Houston Cardiology's merger into region's leading physician-owned medical group increases case volume, slashes overhead expenses while boosting physician and patient satisfaction.
Read More
Press Release
Feb 26, 2025
Glidewell Publishes Second Patient Education Issue of Chairside(R) Magazine
The patient edition of Chairside magazine educates patients on the power of dentistry
Read More
Press Release
Feb 26, 2025
Telomir Pharmaceuticals Announces Breakthrough: Telomir-1 Reverses Calcium Dysregulation, the Hidden Driver of Aging and Disease, in Multiple Human Cell Lines
New Study Confirms Telomir-1 Also Reverses Oxidative Stress, Preserves Cellular Integrity, and Prevents Cell Death by Protecting Mitochondria-The Cell's Power Source and Gatekeeper of Life and Death
Read More
Press Release
Feb 26, 2025
Northernmost Enters Into Know-How Agreement With Mayo Clinic to Collaborate on Development of NoMo Kidney Pump
Read More
Press Release
Feb 26, 2025
CBD Life Sciences Inc. (CBDL) Launches Mushroom Powder Capsules
The Global Functional Mushroom Market is Set to Surpass $19 Billion by 2030—CBDL Enters the Booming Industry with Premium Mushroom Capsules for Cognitive Enhancement, Immune Support & Longevity!
Read More
Press Release
Feb 26, 2025
Interactive Strength Inc. (Nasdaq:TRNR) Launches FAQ's About Acquisition, Business Strategy and $50M Pro Forma 2025 Guidance
Company Encourages Shareholders to Sign Up for Direct Email Updates
Read More
Press Release
Feb 25, 2025
MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for Canada
Read More
Press Release
Feb 25, 2025
Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando
Read More
Press Release
Feb 25, 2025
CGFNS International to Change Its Name to TruMerit
Rebranding heralds greater focus on building a future-ready global healthcare workforce
Read More
Press Release
Feb 25, 2025
CORRECTION FROM SOURCE: Royal Biologics Announces Strategic Partnership With Coldplasmatech GmbH
This Press Release updates an error in the sub headline Strategic Partnership: Royal Biologics and Coldplasmatech Revolutionize Complex Wound Care
Read More
Press Release
Feb 25, 2025
Innovaccer Earns Top Ranking in 2025 Black Book Survey Under New Rigorous AI-Specific KPIs for Population Health Management
Black Book Research Introduces 18 AI-Focused KPIs to Deeply Evaluate Machine Learning, Data Integration, and Real-World Impact in Population Health and Value-Based Care
Read More
Press Release
Feb 25, 2025
InTheZone Labs Accelerates Growth Strategies, Builds Momentum With Positive User Feedback
Read More
Press Release
Feb 25, 2025
Incredible KLAS Outcomes! AGFA HealthCare Achieves Triple KLAS Wins and Excels in PACS Radiology & Cardiology Ratings in USA!
Read More
Press Release
Feb 25, 2025
Black Book Research Unveils 2025’s Top-Rated Population Health & Value-Based Care Vendors: AI, Interoperability, and ROI Take Center Stage
New Industry KPIs for Evaluating PHM & VBC IT Vendors Prioritize AI-Driven Insights, Workflow Automation, and Real-World Clinical Impact - Top 2025 Vendors Recognized for Effectiveness and Client Experience
Read More
Press Release
Feb 25, 2025
Royal Biologics Announces Strategic Partnership With Coldplasmatech GmbH
Strategic Partnership: RoStrategic Partnership: Royal Biologics and Coldplasmatech Revolutionize Complex Wound Careyal Biologics and Coldplasmatech Revolutionize Complex Wound Care
Read More
Press Release
Feb 25, 2025
StimCell Energetics Partners With ADM Tronics to Redesign eBalance Microcurrent Device for Home Use
Innovative Redesign Brings Smaller, Cost-Effective Unit with Advanced Diagnostics to Consumers
Read More
Press Release
Feb 25, 2025
NOK Therapeutics, Inc. to Attend 10th Annual Innate Killer Summit in San Diego
Read More
Press Release
Feb 25, 2025
Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Botulinum Toxin Treatment for Hyperhidrosis
- This would be Dermata's second patent for DMT410, if issued, using its Spongilla technology to topically deliver botulinum toxin for hyperhidrosis - - The Company recently entered into a Clinical Trial Collaboration Agreement with Revance to study DMT410 for the treatment of axillary hyperhidrosis - - The Company also has an issued patent in Japan covering their DMT410 program for the treatment of hyperhidrosis -
Read More
Press Release
Feb 25, 2025
Aspire Biopharma Holdings, Inc., Provides an Update on Lead Product Candidate: High-Dose, Sublingual Aspirin
Initial feasibility study of its soluble, Ph neutral, fast acting granular or powder drug delivery system is complete Test results support the next development step with Phase 1clinical trial expected to commence in April Provides Summary of Expected 2025 Milestones
Read More
Press Release
Feb 25, 2025
CTT Pharma Gives Update On U.S. and European Patents
Read More
Press Release
Feb 25, 2025
Moderna to Present at Upcoming Conferences in March 2025
Read More
Press Release
Feb 25, 2025
DOJ Makes Major Announcement - a Major Boost for MMJ'S Cannabis Research and DEA Accountability
The Department of Justice (DOJ) has announced that it will no longer defend statutory protections that currently shield Administrative Law Judges (ALJs) from removal. This significant shift is expected to bolster MMJ International Holdings' ongoing lawsuit against the Drug Enforcement Administration (DEA), which has been criticized for stalling MMJ's application to cultivate pharmaceutical-grade marijuana for medical research.
Read More
Press Release
Feb 24, 2025
Desert Oasis Healthcare Honored with Dual Accolades in 2024 Best of Desert Awards
DOHC won Best Home Health Care Services and Best Nurse/Nurse Practitioner
Read More
Press Release
Feb 24, 2025
Discovery Senior Living Appoints President of Integral Senior Living
Read More
Press Release
Feb 24, 2025
The Assistance Fund Opens New Program for Familial Chylomicronemia Syndrome
Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Familial Chylomicronemia Syndrome
Read More
Press Release
Feb 24, 2025
PharmPix Announces Entry Into the Medicare Market With Launch of Proprietary Innovative Technology, MedArk(TM)
PharmPix further positions itself as a leader in the pharmacy benefit management arena as they are proud to announce their expansion into the Medicare market with the launch of MedArk™, a transformative platform designed to meet the complex needs of Medicare Part D plans.
Read More
Press Release
Feb 24, 2025
Ankle & Foot Centers of America Highlights Critical Link Between Foot Health and Heart Health
During American Heart Month, the leading podiatry group is highlighting how evaluations of health issues with the feet can provide early detection of cardiovascular issues.
Read More
Press Release
Feb 24, 2025
Building to Meet the Need for Care During Mental Health Crisis
Spring Lake Ranch Therapeutic Community launches 18MM Capital Campaign.
Read More
Press Release
Feb 24, 2025
B. Braun Settles Ethylene Oxide Litigation
What Does This Mean for the Future of EO Sterilization?
Read More
Press Release
Feb 21, 2025
Black Book Research Releases 2025 Rural Healthcare IT Solutions Report Addressing Interoperability Challenges & Technology Gaps
Meet Black Book top rated IT vendors at the AHA Rural Healthcare Leadership Conference
Read More
Press Release
Feb 21, 2025
New Guidelines Released for Self-Collected HPV Screening
Read More
Press Release
Feb 21, 2025
Telomir Pharmaceuticals Achieves Breakthrough in Silver Ion Stabilization, Unlocking a Multi-Billion-Dollar Medical Market
Read More
Press Release
Feb 21, 2025
Protagonist Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
$165.0 million icotrokinra (formerly JNJ-2113) milestone earned in Q4 2024, received in January 2025 PN-881, a potential best-in-class oral IL-17 receptor antagonist peptide nominated as a development candidate in Q4 2024 Topline results for rusfertide Phase 3 VERIFY clinical trial in polycythemia vera expected in March 2025 Topline results for icotrokinra Phase 2b ANTHEM clinical trial in moderate to severe ulcerative colitis expected in March 2025 Cash, cash equivalents, and marketable securities of $559.2 million as of December 31, 2024, combined with $165.0 million milestone payment, anticipated to provide cash runway through at least end of 2028
Read More
Press Release
Feb 20, 2025
Aspire Biopharma Holdings, Inc. Announces the Execution of Securities Purchase Agreement
Read More
Press Release
Feb 20, 2025
10 Hunt School of Dental Medicine Inaugural Class Members Clinch Elite Residencies
Read More
Press Release
Feb 20, 2025
Emergency Care Partners and Professional Emergency Medicine Management Expand Services to Rapides Regional Medical Center
Read More
Press Release
Feb 20, 2025
Prolocor to Present New Clinical Evidence at ACC 25 Supporting Use of PLATELET FCɣRIIA (PFCG) As Key Tool In Individualizing Dual Antiplatelet Therapy (DAPT)
Date: March 31, 2025, 10:36 A.M. Location: Moderated Poster Theater 7 PROGNOSTIC IMPLICATIONS OF PLATELET FCÉ£RIIA DURING THE FIRST YEAR AFTER MYOCARDIAL INFARCTION
Read More
Press Release
Feb 20, 2025
Glidewell Launches Glidewell(TM) Tooth Replacement Solution for Implant Treatment
A comprehensive, cost-cutting bundle offers a streamlined digital workflow from guided implant placement to delivery of the final restoration.
Read More
Press Release
Feb 20, 2025
TridentCare Joins Southwestern Health Resources Preferred Provider Network to Expand Portable Diagnostic Services to ACO Members Across North Texas
Read More
Press Release
Feb 20, 2025
The Longevity Centers Introduces Stellate Ganglion Block (SGB) Injections for Nervous System Regulation
With the addition of SBG injections, the West Palm Beach integrative health clinic offers a new option to individuals looking for relief from chronic pain, trauma disorder, and other ailments
Read More
Press Release
Feb 20, 2025
Grant Porteous Joins ACU-Serve as New Chief Technology Officer
Read More
Press Release
Feb 20, 2025
IGC Pharma Expands Holiby(TM) Product Line With 'Longevity' and 'Renew' - Targeting the Multi-Billion-Dollar Anti-Aging Market
- New science-backed formulations designed to support cellular health, energy metabolism, and cognitive function -
Read More
Press Release
Feb 20, 2025
ZetrOZ Systems' Dr. Rajiv Mallipudi to Present Webinar on Sustained Acoustic Medicine for Workplace Injuries
Education event for occupational and environmental medicine physicians will cover biomechanics, research and clinical indications for use of long-duration ultrasound treatment for soft-tissue injury healing.
Read More
Press Release
Feb 20, 2025
Dr. Amir Bajoghli and Skin & Laser Dermatology Center Introduce Ultherapy for Non-Invasive Skin Lifting and Tightening
Read More
Press Release
Feb 20, 2025
Best Rated Dentists in Austin 2025 by TopRatedDentist.com
Read More
Press Release
Feb 20, 2025
Best Rated Dentists in Dallas 2025 by TopRatedDentist.com
Read More
Press Release
Feb 20, 2025
Best Rated Dentists in Houston 2025 by TopRatedDentist.com
Read More
Press Release
Feb 20, 2025
Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq
The closing of the business combination with PowerUp Acquisition Corp. creates Nasdaq-listed biopharmaceutical company dedicated to developing breakthrough innovations in FDA approved drugs, nutraceuticals, and supplements Aspire has multiple product candidates in key areas of medical needs such as a fast-acting aspirin product for cardiology emergencies and pain management, a proprietary Viagra/Cialis combination product, various bi-hormonal drugs such as testosterone, estrogen, weight loss, anti-seizure, and thyroid drugs. Supplements such as pre-workout and melatonin are already being developed using Aspire's proprietary sublingual delivery system. Aspire Biopharma Holdings, Inc. ("Aspire Biopharma") is scheduled to begin trading on Nasdaq on February 20, 2025 under the ticker symbol "ASBP".
Read More
Press Release
Feb 19, 2025
Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq
Read More
Press Release
Feb 19, 2025
Sober Safe Spot Returns to Mardi Gras for the Fourth Year
Read More
Press Release
Feb 19, 2025
CNY Fertility Supports Executive Order to Expand IVF Access and Reduce Costs
CNY Fertility Founder & CEO Dr. Robert Kiltz Applauds President Trump's Directive to Protect IVF Access and Aggressively Reduce Out-of-Pocket and Health Plan Costs for Fertility Treatment
Read More
Press Release
Feb 19, 2025
Jaguar Receives Regulatory Clearance in Germany and Italy for Crofelemer for Rare Disease Study - Short Bowel Syndrome with Intestinal Failure (SBS-IF)
This study, initiated yesterday, is one of five clinical efforts - three proof-of-concept (POC) investigator-initiated trials (IIT) and two Phase 2 studies - of crofelemer for the rare disease indications of SBS-IF and microvillus inclusion disease (MVID) in the US, EU, and/or Middle East/North Africa regions Availability of first IIT proof-of-concept results potentially in H1 2025 Crofelemer, Jaguar's novel plant-based prescription drug, has been granted Orphan-Drug Designation by the FDA and the European Medicines Agency (EMA) for both SBS-IF and MVID
Read More
Press Release
Feb 19, 2025
DEXIS Showcases Newest Technology at Chicago Midwinter and Lab Day Conferences
The global leader in dental imaging technologies will showcase the latest innovations added to its digital ecosystem - a suite of tools and software designed to connect the entire digital workflow from diagnosis to delivery.
Read More
Press Release
Feb 19, 2025
Doron Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for MOTYS for Treatment of Symptoms Associated With Osteoarthritis
RMAT and Fast Track Designation
Read More
Press Release
Feb 19, 2025
Interactive Strength Inc. (Nasdaq:TRNR) Increases 2025 Expectations to More Than $50M in Pro Forma Revenues
New Investor Presentation on Growth Strategy and Expected Sportstech Acquisition
Read More
First
Prev
34
35
36
37
38
39
Next